Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1152 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Tideglusib for congenital myotonic dystrophy	Tideglusib (AMO-02; Zentylor; Nypta; NP031112)	Myotonic dystrophy	Genetic Disorders , Musculoskeletal System , Neurology	2020	View \| Download
Timolumab for Primary Sclerosing Cholangitis	Timolumab (BTT1023)	Primary sclerosing cholangitis (PSC)	Hepatology	2018	View \| Download
Timrepigene emparvovec for choroideremia	Timrepigene emparvovec (BIIB111; AAV2-REP1; NSR-REP1)	Choroideremia	Ophthalmology	2020	View \| Download
Tiragolumab with atezolizumab and pemetrexed and carboplatin or cisplatin for previously untreated advanced non-small-cell lung cancer	Atezolizumab (Tecentriq; MPDL3280A) , Tiragolumab (RG-6058; MTIG7192A)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Tiragolumab with atezolizumab for oesophageal squamous cell cancer	Atezolizumab (Tecentriq; MPDL3280A) , Tiragolumab (RG-6058; MTIG7192A)	Oesophageal squamous cell carcinoma	Head and Neck Cancer	2023	View \| Download
Tiragolumab with atezolizumab for previously untreated non-small cell lung cancer	Atezolizumab (Tecentriq; MPDL3280A) , Tiragolumab (RG-6058; MTIG7192A)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2022	View \| Download
Tiragolumab with atezolizumab for treating stage III non-small cell lung cancer after platinum-based chemoradiotherapy	Atezolizumab (Tecentriq; MPDL3280A) , Tiragolumab (RG-6058; MTIG7192A)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2023	View \| Download
Tiratricol for treating monocarboxylate transporter 8 deficiency (Allan-Herndon-Dudley syndrome)	Tiratricol	Monocarboxylate transporter 8 deficiency (Allan-Herndon-Dudley syndrome)	Genetic Disorders , Neurology	2022	View \| Download
Tirzepatide for treating obese or overweight adults	Tirzepatide (LY3298176)	Obesity	Cardiovascular System , Ear Nose and Throat (ENT)	2022	View \| Download
Tirzepatide for treating type 2 diabetes mellitus	Tirzepatide (LY3298176)	Type 2 diabetes	Endocrine Nutritional and Metabolic Disorders	2021	View \| Download